Skip to main
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is well-positioned in the post-acute healthcare market with strong earnings and growth in SS volume. Despite potential risks, the company has a successful track record of expansion and a strong balance sheet. Their focus on EBITDA and margin growth, as well as their strategic prioritization of favorable markets and pilot programs, shows a commitment to continued success and potential for further growth. Additionally, the company has strong leadership and partnership with experienced executives and a history of success in the post-acute healthcare market.

Bears say

Encompass Health is facing potential risks from stricter reimbursement and regulatory measures, as well as slow recovery of demand and patient volume growth which is putting pressure on margins. Despite a strong balance sheet and management expertise, their prioritization of investing in existing facilities and partnerships for new facilities, and their position in the IRF market, they may face challenges with potential lower volume growth, slower ramp-up of new facilities, and pressure from Medicare Advantage payers in the future. Their successful growth strategy and plans to increase leverage for further growth opportunities may pose a potential risk if the economic climate changes or if they are unable to maintain their strong competitive position.

Encompass Health (EHC) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Sep 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $148.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $148.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.